Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities:
Net loss	$ (3,175,435)	$ (834,281)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	25,006	25,318
Stock-based compensation expense	2,167,595	0
Rental inventory – depreciation expense	131,134	0
Amortization of right of use assets	0	10,008
Changes in operating assets and liabilities:
Accounts receivable	5,235	0
Prepaid expenses	(20,000)	477,000
Right of use asset	(18,192)	0
Rental inventory	(112,695)	(1,590,000)
Accounts payable and accrued liabilities	15,488	(100,178)
Right of use liabilities	18,192	(10,308)
Net cash used in operating activities	(963,672)	(2,022,441)
Cash Flows from Investing Activities:
Capitalized patent costs	0	0
Purchases of property and equipment	0	0
Net cash used in investing activities	0	0
Cash Flows from Financing Activities:
Repayment on notes payable	0	(74,500)
Repayment of line of credit	0	(128,466)
Repayment of related party advances	(8,731)	0
Repayment of notes payable – related party	(199,750)	0
Proceeds from note payable	99,996	0
Proceeds from notes payable – related party	94,750	0
Proceeds from sale of common stock	1,102,264	2,089,300
Net cash provided by financing activities	1,088,529	1,886,334
Net change in cash	124,857	(136,107)
Cash, at beginning of period	38,971	278,756
Cash, at end of period	163,828	142,649
Supplemental disclosures of cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	$ 0	$ 0